Charles River Laboratories | Passivo Circulante



Current Liabilities Alterar Data
Agilent USD 1.89B 120M 2025-07
Align Technology USD 2B 4.54M 2025-06
Bio-Rad Laboratories USD 548.9M 42.3M 2025-06
Bruker USD 1.35B 2.5M 2025-06
Cardinal Health USD 38.9B 2.24B 2025-06
Charles River Laboratories USD 1.08B 29.38M 2025-06
Cigna USD 56.78B 1.03B 2025-06
CVS Health USD 94.16B 5.2B 2025-06
Danaher USD 6.79B 147M 2025-06
Dentsply International USD 1.17B 627M 2025-06
Elevance Health 43.83B 1.14B 2025-06
Galapagos EUR 402.95M 34.09M 2025-06
Hologic USD 962.5M 27.2M 2025-06
Humana 18.04B 1.1B 2025-03
Illumina USD 1.46B 21M 2025-06
Incyte USD 1.28B 608.18M 2025-06
IQVIA Holdings USD 7.57B 393M 2025-06
Laboratory Of America USD 2.72B 652.2M 2025-06
Lonza CHF 3.58B 970M 2024-12
McKesson USD 64.33B 2.73B 2025-06
Merck EUR 9.86B 357M 2025-06
Mettler Toledo International USD 1.11B 42.8M 2025-06
Novartis USD 31.71B 95M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Quest Diagnostics USD 2.02B 583M 2025-06
Revvity USD 671.81M 23.63M 2025-06
Thermo Fisher Scientific USD 12.72B 456M 2025-06
United Therapeutics USD 527.1M 194.4M 2025-06
UnitedHealth 113.47B 9.7B 2025-03
Waters USD 1.02B 55.16M 2025-06
West Pharmaceutical Services USD 604.6M 77.9M 2025-06


Charles River Laboratories Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Sep 2025.